Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT
Article in Advances in Therapy (March 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Advances in Therapy (March 2024)
Article in Research in Social and Administrative Pharmacy (March 2023)
Article in Experimental and Applied Biomedical Research (EABR) (December 2022)